ADIPOQ and metabolic syndrome: Kilpeläinen et al. [42] reported a locus near IRS1 which was associated with a decrease in BF but with an impaired metabolic profile, including increased insulin resistance, dyslipidemia, risk of diabetes and coronary artery disease, and decreased adiponectin levels.